
IKORODU, LAGOS – The long-drawn legal battle over the paternity of Liam Aloba, son of the late singer Ilerioluwa Aloba (popularly known as Mohbad), reached a critical turning point yesterday, February 3, 2026. In a move to ensure “absolute scientific certainty,” an Ikorodu Magistrate Court has ordered a rigorous triple-testing protocol involving three independent foreign-affiliated facilities.
The “Triple-Result” Mandate
In a ruling aimed at eliminating any room for discrepancy, the court directed that three separate tissue-based DNA tests be conducted. The selection process for the laboratories will be a collaborative yet independent effort:
- The Father’s Side: Joseph Aloba’s legal team will submit a list of three foreign-capable facilities.
- The Widow’s Side: Wunmi Aloba’s legal team will also submit three facilities.
- The Court’s Selection: From these lists, the court will select one facility from each party’s suggestions.
- The Independent Tie-Breaker: The court will appoint a third, entirely independent facility of its own choosing.
Legal experts note that for the paternity results to be legally binding and conclusive, all three results must correspond.
Shunning Government Pathologists
A significant highlight of the hearing was the stance taken by the late singer’s father, Joseph Aloba. Through his legal representative, the family expressed a lack of confidence in using government-run laboratories.
Citing the “inconclusive” nature of the initial state-led autopsy—which previously failed to determine Mohbad’s cause of death due to decomposition—the family’s lawyer argued for private expertise.
”We do not wish to risk a repeat of the past,” the lawyer stated. “We prefer foreign facilities that have specialized pathologists operating within Nigeria to ensure a world-class chain of custody and technical precision.”
Cost and Logistics
The financial burden of this extensive testing was also addressed. The court ruled that Joseph Aloba will bear the costs for his nominated test as well as the court-appointed independent test. Wunmi Aloba’s team will be responsible for the costs associated with their selected facility.
The use of tissue-based testing (rather than simple blood or swab samples) is a specific request by the Aloba family to ensure the samples are directly compared against the late singer’s biological remains, ensuring the most accurate post-mortem parentage analysis possible.
What Happens Next?
The court has adjourned the matter to February 10, 2026, for the formal submission of the selected facilities and to finalize the logistics for sample collection.
Do you want to advertise with us?
Do you need publicity for a product, service, or event?
Contact us on WhatsApp +2348033617468, +234 816 612 1513, +234 703 010 7174
or Email: validviewnetwork@gmail.com
CLICK TO JOIN OUR WHATSAPP GROUP


